Key Highlights of the Next-Generation Sequencing Data Analysis Market 2025-2034: Growth Dynamics, Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Next-Generation Sequencing Data Analysis Market Over the 2025–2034 Period?
The market size for next-generation sequencing data analysis has shown immense growth in recent years and is projected to expand from $1.21 $ billion in 2024 to $1.48 $ billion in 2025, experiencing a compound annual growth rate (CAGR) of 22.0%. The notable growth in the previous period can be credited to its proliferating use for pathogen identification, implementation in veterinary diagnostics and studies, escalating use for detecting rare genetic diseases, enhanced focus on microbiome research, and the amplified use of NGS in the field of pharmacogenomics.
The market size for next-generation sequencing data analysis is anticipated to experience substantial growth in the coming years, reaching $3.24 billion by 2029 with a compound annual growth rate (CAGR) of 21.7%. The acceleration during this forecast period could be credited to the increased emphasis on integrating genomics into the healthcare sector, educational initiatives for healthcare practitioners, the focus on public health surveillance, cut down on sequencing costs, and the growing fascination with epigenetic studies. Essential trends for this projection period include progression in single-cell sequencing, automation advancements within NGS data assessment, improvements in NGS data visualization tools, the incorporation of blockchain technology, and the evolution of hybrid sequencing methods.
Which Factors Are Enhancing the Growth of the Next-Generation Sequencing Data Analysis Market?
The rise in cancer incidence is projected to stimulate the expansion of the next-generation sequencing data analysis market. Cancer is a collection of diseases marked by uncontrolled proliferation and dissemination of abnormal cells, leading to potential health challenges or even death if left untreated. Things like smoking, excessive alcohol intake, and a diet heavy in processed foods and lacking in fruits and vegetables may heighten cancer risk. The next-generation sequencing data analysis enhances cancer treatment by accurately pinpointing genetic modifications, facilitating personalized treatments and more effective strategy planning based on each individual’s unique genetic cancer profile. For example, the World Health Organization, an intergovernmental organization based in Switzerland, projected in February 2024 that by 2050, there would be over 35 million new cases of cancer, indicative of a 77% rise in comparison to the estimated 20 million cases in 2022. Consequently, the rising incidence of cancer is fostering the expansion of the next-generation sequencing data analysis market.
Explore Comprehensive Insights Into The Global Next-Generation Sequencing Data Analysis Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19614&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Next-Generation Sequencing Data Analysis Market?
Major companies operating in the next-generation sequencing data analysis market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., MedGenome Inc., Element Biosciences Inc., Seven Bridges Genomics Inc., Synthego Corp., Eurofins Genomics India Pvt. Ltd., Fabric Genomics Inc., Strand Life Sciences Pvt. Ltd., Admera Health LLC, Congenica Ltd., DNASTAR Inc., Golden Helix Inc., Geneious, SciGenom Labs Pvt. Ltd., Partek Incorporated, PathoQuest SAS, BioDatomics Inc., BGI Genomics Co. Ltd
Which Cutting-Edge Trends Are Expected to Drive the Next-Generation Sequencing Data Analysis Market’s Growth?
Leading businesses involved in the next-generation sequencing data analysis sector are concentrating on creating sophisticated secondary analysis bioinformatics software. This enhanced software can facilitate the quick and accurate detection of genetic variations for research and clinical uses. Secondary analysis bioinformatics software processes raw sequencing information from next-generation sequencing (NGS) and transforms it into formats that are easy to interpret, such as variant call files (VCF), which provide information on genetic variations. This specialized software simplifies the assessment of NGS data for research and clinical objectives. For example, in January 2024, QIAGEN Digital Insights, QIAGEN’s bioinformatics division in the USA, introduced its QIAGEN CLC Genomics Workbench Premium using LightSpeed technology. This novel software is designed to expedite next-generation sequencing (NGS) in the field of somatic cancer analysis and rapidly process whole genome sequencing (WGS) samples. It has the capacity to process 34x human genomes in 25 minutes and 50x exomes in 90 seconds with the help of LightSpeed technology, which effectively transforms raw FASTQ data into easily interpretable formats. This software is a budget-friendly option for high-capacity laboratories, with expenses as little as $1 for genomes and a few cents for exomes when using cloud infrastructure. The software can operate on standard hardware or cloud-based platforms, providing versatility and a high level of precision, making it an excellent choice for clinical application and reducing its environmental impact.
Secure Your Global Next-Generation Sequencing Data Analysis Market Report Now for Fast and Efficient Delivery!
What Are the Major Categories and Their Growth Dynamics in the Next-Generation Sequencing Data Analysis Market?
The next-generation sequencing data analysismarket covered in this report is segmented –
1) By Product: Services, Next-Generation Sequencing (NGS) Commercial Software
2) By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing
3) By Mode: In-House, Outsourced
4) By Workflow: Primary, Secondary, Tertiary
5) By End-User: Academic Research, Clinical Research, Hospitals And Clinics, Pharma And Biotech Entities, Other End-Users
Subsegments:
1) By Services: Data Analysis Services, Bioinformatics Services, Consulting Services, Sample Preparation Services, Training and Support Services
2) By Next-Generation Sequencing (NGS) Commercial Software: Data Management Software, Alignment Software, Variant Calling Software, Visualization Software, Pipeline Management Software, Specialized Analysis Software
Which Regions Are Most Influential in Expanding the Next-Generation Sequencing Data Analysis Market?
North America was the largest region in the next-generation sequencing data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does the Definition of the Next-Generation Sequencing Data Analysis Market Include?
Next-generation sequencing (NGS) data analysis is the process of understanding the large amounts of data generated by high-throughput sequencing technologies for DNA or RNA. Its primary purpose is to decipher genetic variants and mutations, which helps with illness detection, biomarker discovery, and biological process understanding. This study is critical for increasing customized medicine, focused treatments, and improving diagnostic precision.
Browse Through More Similar Reports By The Business Research Company:
Next-Generation Antibody Therapeutics Global Market Report 2024
Next-Generation Network Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/next-generation-network-global-market-report
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
